Probes & Drugs

**Probes & Drugs (P&D)** is a comprehensive platform designed to integrate high-quality bioactive compound sets for in-depth analysis and comparison. Launched with the latest version in February 2024, P&D features an expansive database comprising 91 sources, which include specialized collections for chemical probes and drugs. The current repository boasts over 132,000 original compounds, along with substantial sets of standardized and non-isomeric compounds.

P&D focuses on unique offerings such as experimental, calculated, and approved bioactive compounds, while also featuring obsolete and free-of-charge probes. With extensive biological annotations sourced from reputed databases like ChEMBL, BindingDB, and DrugCentral, researchers can efficiently explore compound-target associations across various pathways and structural alerts. The platform provides tools for complex queries, enabling users to identify compounds based on specific pharmacological criteria. By continuously updating and enriching its offerings, the P&D portal serves as an essential resource for scientists and pharmacologists seeking reliable data on chemical probes and approved drugs.